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OBJECTIVE — It is recommended that the psychological status of adolescents with diabetes
be assessed periodically as part of ongoing care. The World Health Organization-Five Well-Being
Index (WHO-5) is a short self-report instrument that appears suitable for this purpose. This
study is the first to assess the reliability and validity of the WHO-5 in adolescents with type 1
diabetes.
RESEARCH DESIGN AND METHODS — Ninety-one adolescents with type 1 diabetes
(aged 13–17 years) from four pediatric clinics completed the WHO-5, along with other psycho-
logical measures: the Center for Epidemiologic Studies Depression Scale (CES-D), the Diabetes
Family Conflict Scale (DFCS), and the mental health and self-esteem subscales of the Child
Health Questionnaire (CHQ-CF87). Confirmatory factor analysis (CFA) and exploratory factor
analysis were conducted. Readability, homogeneity, and item-total and inter-item correlations
were determined. Concurrent validity was examined by calculating correlation coefficients
among all measures. Sensitivity and specificity of the WHO-5 were tested against those for the
CES-D using receiver operating characteristic (ROC) curves.
RESULTS — CFA confirmed the one-factor structure; Cronbach’s  of this 5-item scale was
0.82. The WHO-5 showed a moderate to strong correlation with the CES-D (r  0.67), with
the mental health (r  0.60) and self-esteem (r  0.43) subscales of the CHQ-CF87, and with
the DFCS (r  0.34), confirming concurrent validity. ROC curve analysis confirmed the
WHO-5 cutoff point of 50 for identification of mild to severe depressive affect (sensitivity 89%
and specificity 86%).
CONCLUSIONS — The WHO-5 is a brief, patient-friendly measure of positive well-being
with good psychometric properties that appears suitable for routine use in adolescents with type
1 diabetes.
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D epression appears to be two to threetimes more prevalent in adolescentswith diabetes compared with ado-
lescents in the general population and ad-
versely affects quality of life and diabetes
outcomes (1–4). It is therefore recom-
mended that screening for depression be
performed routinely in this age-group,
but there is no consensus on which mea-
sure to use for this purpose (1–3,5). The
World Health Organization-Five Well-
Being Index (WHO-5) is a short, posi-
tively worded instrument designed to
assess the level of emotional well-being
over a 14-day period. The screening prop-
erties of the WHO-5 have been studied in
adults with and without diabetes against
the Structured Clinical Interview for the
Diagnostic and Statistical Manual (DSM)-
IV, showing excellent sensitivity (94 –
100%) and specificity (78%) (6,7). Given
its brevity and focus on positive affect, the
WHO-5 may be a suitable instrument to
screen for low emotional well-being and
depressive affect in adolescents with dia-
betes. Moreover, as the WHO-5 is a ge-
neric measure, it allows for comparison
with healthy peers and is available in a
multitude of languages. However, only
one study so far used the WHO-5 in
young men, but no validation data were
reported (8). We therefore set out this
study to investigate the reliability and va-
lidity of the WHO-5 in adolescents with
type 1 diabetes.
RESEARCH DESIGN AND
METHODS — Participants between
the ages of 13 and 17 years were recruited
from four pediatric outpatient clinics in
the Netherlands as part of a larger psycho-
social research project. Insufficient lan-
guage skills and diabetes duration 6
months were exclusion criteria. Of the to-
tal 171 eligible subjects, 91 adolescents
with type 1 diabetes consented to partic-
ipate. The study was approved by the
medical ethical committees of all hospi-
tals, and written informed consent was
obtained from both patients and parents.
The adolescents who chose not to partic-
ipate did not differ in age, sex, or A1C
from participating adolescents. Nonpar-
ticipants were, however, more likely to be
from an ethnic minority.
Measures
The WHO-5 captures emotional well-
being and was developed from the World
Health Organization-Ten Well-Being In-
dex (9,10). It was conceptualized as a uni-
dimensional measure that contains five
positively worded items: “I have felt
cheerful and in good spirits;” “I have felt
calm and relaxed;” “I have felt active and
vigorous;” “I woke up feeling fresh and
rested;” and “My daily life has been filled
with things that interest me.”
The degree to which the aforemen-
tioned positive feelings were present in
the last 2 weeks is scored on a 6-point
Likert scale ranging from 0 (not present)
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to 5 (constantly present). The raw scores
are transformed to a score from 0 (worst
thinkable well-being) to 100 (best think-
able well-being). A score 50 suggests
poor emotional well-being and is a sign
for further testing. A score 28 is indica-
tive of depression (6). In adults, the
WHO-5 proved to be a highly sensitive
screener for depressive affect (6,7).
In addition to the WHO-5, the Center
for Epidemiologic Studies Depression
Scale (CES-D), two subscales of the 87-
item child report version of the Child
Health Questionnaire (CHQ-CF87) eval-
uating mental health and self-esteem, and
the Diabetes Family Conflict Scale
(DFCS) were completed.
The CES-D consists of 20 items (4
positive and 16 negative) and is scored
from 0 (never) to 3 (daily) on the basis of
frequency of depressive symptoms re-
ported in the past week (11). Total CES-D
summation scores range from 0 (no de-
pressive symptoms) to 60 (most frequent/
severe depressive symptoms). In adults, a
cutoff score of 16 is used to define likely
depression. However, this criterion has
yielded mixed results in adolescents (12–
15), and a cutoff of 24 was suggested to
improve the correlation with depression
defined according to the DSM-III revised
(16). Similar to the U.S. National Longi-
tudinal Study of Adolescent Health and
the SEARCH for Diabetes in Youth Study,
we adapted this cutoff score and stratified
depressive affect as “minimal” (0 –15),
“mild” (16–23), and “moderate/severe”
(24) (3,17).
The mental health (16 items) and self-
esteem (14 items) subscales of the CHQ-
CF87 are scored from 1 to 5 and
transformed to a score between 0 and
100, with higher scores representing bet-
ter well-being. The ratings of all scales are
based on children’s functioning over the
previous 4 weeks (18).
The version of the Diabetes Family
Conflict Scale (DFCS) adapted by Laffel
and colleagues assesses the current degree
of family conflict on 19 management tasks
rated on a 3-point Likert scale (19). The
DFCS does not specify a time frame.
Higher scores indicate more conflicts.
Statistical analyses
Because the WHO-5 was originally devel-
oped for adults, it is important to assess
the readability of the measure. For this
purpose, we calculated the Flesch Read-
ing Ease score. This score is based on the
average number of syllables per word and
the average sentence length. Higher
scores represent better readability; eighth
grade students could easily understand
passages with a score of 70 (20).
Confirmatory factor analysis (CFA)
was conducted by structural equation
modeling to confirm the factor structure
established in adult studies, using Mplus
(version 3.13). The 2, root mean square
error of approximation (RMSEA), and
comparative fit index (CFI) were calcu-
lated. RMSEA values between 0.08 and
0.10 and CFI values 0.90 are indicative
of adequate fit. An exploratory factor
analysis using principal component anal-
ysis was used to study the appropriate-
ness of this factor structure in our
adolescent population. Only components
with eigenvalues 1.0 should be re-
tained, together explaining 50% of the
total variance and showing factor load-
ings 0.40 (21). Internal consistency by
Cronbach’s  and item-total and inter-
item correlations were calculated to assess
the reliability of the scale. For internal
consistency, an  of 0.70–0.80 is desir-
able, and the item-total correlation
should be 0.20. A high interitem corre-
lation (0.80) is an indication of redun-
dancy and is therefore not desirable. In
contrast, if all correlations are near 0,
there is no meaningful construct (22).
Concurrent validity was examined
by calculating Pearson and Spearman
correlation coefficients among the ques-
tionnaires. For similar constructs, corre-
lations 0.50 are an indication for good
concurrent validity. These correlations
could be expected for the CES-D and
mental health subscale of the CHQ-
CF87. Poor well-being is expected to be
associated with more family conflicts and
low self-esteem, although not to the ex-
tent that it measures the same construct.
We therefore expect moderate correla-
tions between 0.30 and 0.50 (23). The
sensitivity (proportion of truly diseased
individuals identified) and specificity
(proportion of truly nondiseased individ-
uals identified) were investigated using
receiver operating characteristic (ROC)
curve analyses. The cutoff scores used in
adult populations (28 and 50) were re-
lated to the cutoff points of the CES-D
(respectively, 24 and 16).
In addition to the reliability and va-
lidity, differences in sex, ethnicity (Cau-
casian or not), one- or two-parent family,
and treatment regimen were tested using
ANOVA. Correlations between the
WHO-5, age, A1C, BMI, and diabetes du-
ration were explored using Pearson corre-
lation coefficients. SPSS (version 14.0)
was used to perform analyses; P  0.05
was considered a significant difference.
RESULTS — Forty-seven boys and 44
girls with a mean  SD age of 14.9  1.1
years (range 13–16.5 years) were in-
cluded. Diabetes duration was 6.4  4.2
years, and A1C level was 8.8  1.7%
(6.2–15.0%). Of the adolescents, 19%
lived in a single-parent family and 11%
were from an ethnic minority. The score
on the WHO-5 was 63.38  18.9 (4.0–
96.0).
The Flesch Reading Ease score of 90.0
indicated good readability. The CFA con-
firmed the one-factor structure of the
WHO-5 with no significant proportion of
unexplained variance [2  6.75(5), P 
0.24], an RMSEA of 0.062, and a CFI of
0.99. Cronbach’s  was 0.82, and item-
total correlations ranged from 0.50 to
0.72. Interitem correlations ranged from
0.33 to 0.74. The subsequent principal
component analysis also suggested a uni-
dimensional structure of the WHO-5 be-
cause the first eigenvalue was 3.1,
whereas the other eigenvalues were 1.0.
The explained variance was 62.5%, and
the factor loading for the items ranged
from 0.67 to 0.86.
As expected, higher WHO-5 scores
were strongly associated with lower total
CES-D and higher mental health subscale
scores (r  0.67 and 0.60, P  0.001).
More diabetes-specific family conflicts
and lower self-esteem were moderately
associated with lower WHO-5 scores (r 
0.34 and 0.43, respectively; P 
0.001). The positive subscale of the
CES-D and the WHO-5 correlated mod-
erately (r  0.45, P  0.001). WHO-5
scores were not significantly associated
with the clinical variables A1C (r 
0.16, P  0.14), diabetes duration,
treatment regimen, or BMI (data not
shown). WHO-5 scores did not differ for
sex, age, ethnicity, or family structure.
Analyses of the ROC curves con-
firmed the cutoff of 50 to be optimal for
detecting a mild to severe depressive af-
fect (CES-D score 16) (Fig. 1). With a
significant area under the curve of 0.95
(95% CI 0.91–0.99), the sensitivity was
89% with a specificity of 87%. This cutoff
score identified all adolescents with
CES-D 24, indicative of a severe depres-
sive affect. For identification of those ad-
olescents with an indication of a moderate
to severe depressive affect, a cutoff score
of 28 appeared appropriate (Table 1).
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CONCLUSIONS — This is the first
study to examine the psychometric prop-
erties of the WHO-5 in adolescents with
type 1 diabetes. Our findings suggest
good reliability and validity for the
WHO-5, particularly given its brevity. All
items were completed, and readability
scores were sufficient. It would therefore
seem safe to conclude that the WHO-5 is
a suitable instrument to use in adolescents.
The unidimensional structure of the
questionnaire was confirmed in explor-
atory factor analysis and CFA in our ad-
olescent population. Further research is
needed to examine the stability (test-
retest) and responsiveness of the
WHO-5 in adolescents. Concurrent va-
lidity was confirmed by the moderate to
strong correlations with other relevant
questionnaires. It would appear that the
difference in time frames among the
WHO-5 (past 2 weeks), the CES-D (past
week), and the CHQ-CF87 (past 4
weeks) has not decreased the strength of
the associations.
The WHO-5 measures (the absence
of) positive affect rather than the presence
of negative emotions. The strong correla-
tion between the WHO-5 and the nega-
tively worded items of the CES-D seems
to favor the conceptualization of well-
being as a continuum, with well-being
and depressive affect as extremes rather
than orthogonal dimensions (24). The
WHO-5 was only moderately associated
with the positively worded items of the
CES-D. This lack of association could be
due to the differences in Likert scales and
item content. The WHO-5 is more fo-
cused on vigor and activity, whereas the
positive subscale of the CES-D taps into
feelings of self-worth and pleasure.
In our sample, those adolescents re-
porting low positive affect reported
more negative affect on the CES-D and
vice versa, confirming high sensitivity
for detection of depressive affect by the
WHO-5 in our sample. Although the
presence of positive affect seems not to
be associated with better glycemic con-
trol, more negative affect did show a
moderately strong association with
higher A1C levels in concert with re-
search findings in adults (25).
We found the specificity of the
WHO-5 to be relatively high, suggesting
that the cutoff score of 50 as an indication
for further testing for depression is appro-
priate for both adults and adolescents. It
should be noted that only a few adoles-
cents in our sample reported depressive
symptoms, which could have resulted in
relatively high sensitivity. Further re-
search in a sample of adolescents with
more depressive symptoms is therefore
warranted, with comparison of WHO-5
scores to a diagnostic interview as the
gold standard.
Although previous studies reported
more depressive affect in girls than in
boys, we did not a find such a sex effect
(2,3). The difference in prevalence rates
between boys and girls starts to emerge
at approximately age 15 years, at which
time prevalence rates of depressive af-
fect increase in girls, whereas they re-
main stable in boys (26). The small
sample size and relatively low number
of depressed patients precluded exam-
ining the group of adolescents aged
15 years separately.
The WHO-5 has the advantage of be-
ing a generic measure of emotional well-
being, allowing for comparison of well-
being with that of healthy peers.
Moreover, the scale can also be used to
evaluate parents’ well-being and is freely
available in a multitude of languages
(http://www.who-5.org). However, it
does not capture diabetes-specific distress
for which other reliable instruments are
available (e.g., the Pediatric Quality of
Life Inventory Diabetes Module or the Di-
abetes Quality of Life-Youth) (27). In a
stepped approach, the WHO-5 could be
used as a first screening test alone or in
combination with a diabetes-specific in-
strument, followed by a more extensive
psychological assessment, e.g., using the
Strengths and Difficulties Questionnaire
(28). In summary, the WHO-5 appears to
be a suitable instrument to help detect
and address emotional problems in ado-
lescents with diabetes as part of clinical
routine.
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Table 1—Sensitivity and specificity of the WHO-5 at the two cutoff scores for identifying mild
and moderate to severe depression
CES-D
16 (mild to severe depression) 24 (moderate to severe depression)
Sensitivity Specificity Sensitivity Specificity
WHO-5
28 44 96 67 95
50 89 87 100 82
Data are %.
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